Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1770.66 (Glytoucan)

Id:9e6782e8-309c-584d-974a-ff9fd3f099e6

Glytoucan:G73080AO

Results found

Linked to

	Label	Description
	1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G60090YA-GLYCOSEQ00060057 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G71249CV-GLYCOSEQ00173288 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G27293OK-GLYCOSEQ00153373 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G38316MW-GLYCOSEQ00018980 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G06337UR-GLYCOSEQ00149390 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1770.66 has motif Blood group H (type 2) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G53054ED-GLYCOSEQ00192934 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G58697JA-GLYCOSEQ00158684 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G62364JZ-GLYCOSEQ00170387 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1770.66 has canonical residue n-glycan b-d-glcpnac 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G60090YA-GLYCOSEQ00060057 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G71249CV-GLYCOSEQ00173288 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G27293OK-GLYCOSEQ00153373 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G38316MW-GLYCOSEQ00018980 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G06337UR-GLYCOSEQ00149390 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has motif Blood group H (type 2)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G53054ED-GLYCOSEQ00192934 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G58697JA-GLYCOSEQ00158684 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G62364JZ-GLYCOSEQ00170387 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1770.66 has canonical residue n-glycan b-d-glcpnac 2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.